Menu UF Health Home Menu

Content Tagged Clive Wasserfall Subscribe to RSS Feed


Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes

Published: Nov 21st, 2015

UFDI and nPOD investigators found that the presence of β-cells as well as insulitis several years after T1D diagnosis in children and young adults suggest that the chronicity of islet […]


Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes

Published: Oct 18th, 2015

UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing […]


Immunoproteomic Profiling of Anti-Viral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays

Published: Oct 12th, 2015

UFDI investigators and collaborators at Arizona State University found that the Epstein-Barr virus may have a role in type 1 diabetes development.


UFDI researchers work to develop type 1 diabetes vaccine

Published: Sep 15th, 2015

Two recent publications explored different methods of delivering a vaccine for type 1 diabetes, both of which prevented 40 percent of mice from developing the disease.


UF researchers release publication on the influence of type 1 diabetes on pancreatic weight

Published: Sep 13th, 2015

UFDI faculty and a University of Miami researcher found that “reduced pancreas weight allows for comparisons across a wide range of donor ages by eliminating confounding variables.”


UF researchers publish paper on myxoma virus and T lymphocytes

Published: Aug 26th, 2015

The publication found that myxoma virus binds human T lymphocytes but does not enter and infect T cells until after activation.


$1.5 million grant targets immune cell therapies in Type 1 diabetes

Published: Dec 23rd, 2014

Benjamin Keselowsky, Ph.D. has received a new NIH R01 grant for “Biomaterial Delivery System for Type 1 Diabetes Vaccine”. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases in collaboration with UF Diabetes Institute Director, Mark Atkinson, Ph.D., and Clive Wasserfall, this, $1.5M grant will fund the investigation of biodegradable microparticle/hydrogel formulations delivering immuno-modulatory factors to targeted immune cell types for the prevention and reversal of T1D.


UF Researchers Present at ADA’s 74th Scientific Sessions

Published: Jun 21st, 2014

UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year’s submissions represent one of the largest showcases of research emanating from UF.

OneVax - Copy

Combining efforts to beat Type 1 diabetes

Published: May 29th, 2014

Learn about the latest drug-delivery system developed by University of Florida researches that holds the promise for ways to treat and ultimately prevent persons from developing Type 1 Diabetes. The joint effort is bringing research closer to a cure.

JDRF Network for Pancreatic Organ Donors with Diabetes

JDRF Network for Pancreatic Organ Donors with Diabetes

Published: May 20th, 2010

Visit the JDRF nPOD website The Network for Pancreatic Organ Donors with Diabetes (nPOD) program, supported by JDRF at the University of Florida, is the world’s largest open research consortium […]